Get the Stockscreener App
242.37
1.24%
-3.085
Insulet Corporation stock is traded at $242.37, with a volume of 639.33K.
It is down -1.24% in the last 24 hours and down -3.51% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$245.45
Open:
$240.91
24h Volume:
639.33K
Relative Volume:
0.72
Market Cap:
$17.06B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
73.76
EPS:
3.286
Net Cash Flow:
$382.50M
1W Performance:
-1.16%
1M Performance:
-3.51%
6M Performance:
-29.44%
1Y Performance:
-11.09%
1-Day Range:
$236.51
$243.10
1-Week Range:
$236.51
$253.33
52-Week Range:
$230.05
$354.88
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
242.37 | 17.28B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
113.67 | 198.30B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
383.98 | 148.11B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.96 | 125.95B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
73.88 | 113.10B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.19 | 50.59B | 6.07B | 1.06B | 799.60M | 1.8527 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-12-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-16-25 | Initiated | Evercore ISI | Outperform |
| Nov-19-25 | Upgrade | UBS | Neutral → Buy |
| Oct-21-25 | Resumed | Stifel | Buy |
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Segall Bryant & Hamill LLC Boosts Position in Insulet Corporation $PODD - MarketBeat
CI Investments Inc. Grows Stock Position in Insulet Corporation $PODD - MarketBeat
William Blair Investment Management LLC Sells 289,636 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation (PODD) Stock Analysis: Exploring a Promising 43.71% Upside in the Medical Devices Sector - DirectorsTalk Interviews
TD Asset Management Inc Has $12.22 Million Stake in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Short Interest Down 21.8% in February - MarketBeat
Insulet Corporation $PODD Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet (PODD) - simplywall.st
PODD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Quantbot Technologies LP Cuts Position in Insulet Corporation $PODD - MarketBeat
American Century Companies Inc. Sells 106,813 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation's 10th Straight Year Above 20% Revenue Growth Raises Expectations - Smartkarma
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Westfield Capital Management Co. LP Sells 11,362 Shares of Insulet Corporation $PODD - MarketBeat
Integrated Advisors Network LLC Purchases 6,177 Shares of Insulet Corporation $PODD - MarketBeat
Primecap Management Co. CA Cuts Stock Position in Insulet Corporation $PODD - MarketBeat
Intech Investment Management LLC Boosts Stock Holdings in Insulet Corporation $PODD - MarketBeat
Andra AP fonden Buys 28,800 Shares of Insulet Corporation $PODD - MarketBeat
Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating - Insider Monkey
Insulet: The Growth Doesn't Stop Here - Seeking Alpha
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet (PODD) SVP Prem Singh receives equity awards and withholds shares for taxes - Stock Titan
Insulet (PODD) CAO logs RSU grant, options and tax share withholding - Stock Titan
Equity awards and tax withholding for Insulet (PODD) SVP Kapples - Stock Titan
Insulet (NASDAQ: PODD) COO granted stock and options, withholds shares - Stock Titan
Insulet Corp (PODD) grants stock and option awards to HR chief - Stock Titan
Discipline and Rules-Based Execution in PODD Response - Stock Traders Daily
Eye On Growth: MICHAEL MINOGUE Adds $499K Of Insulet Stock To Portfolio - Benzinga
Insulet (NASDAQ:PODD) Director Michael Minogue Acquires 2,030 Shares of Stock - MarketBeat
Citigroup Inc. Lowers Stake in Insulet Corporation $PODD - MarketBeat
Insulet Hit With Suit Over 401(k) American Century Funds (1) - Bloomberg Law News
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And High P/E Multiple - simplywall.st
P/E Ratio Insights for Insulet - Benzinga
Fox Run Management L.L.C. Buys 4,813 Shares of Insulet Corporation $PODD - MarketBeat
Auditor shift at Insulet (NASDAQ: PODD) as Grant Thornton exits - Stock Titan
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates - simplywall.st
JPMorgan Chase & Co. Sells 5,064,519 Shares of Insulet Corporation $PODD - MarketBeat
O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD) - Finviz
Insulet (PODD) CEO McEvoy buys $1.03 million in shares By Investing.com - Investing.com South Africa
Insulet Corporation (PODD) Stock Analysis: A 46.51% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Hedge Fund and Insider Trading News: Boaz Weinstein, Warren Buffett, Ray Dalio, Bill Ackman, Millennium Management, Point72 Asset Management, Brevan Howard, Insulet Corp (PODD), TTM Technologies Inc, and More - Insider Monkey
Positive Signal: Ashley McEvoy Shows Faith, Buying $1.03M In Insulet Stock - Benzinga
Insulet (PODD) CEO McEvoy buys $1.03 million in shares - Investing.com Australia
Insulet Corp (PODD) CEO Ashley McEvoy buys 4,300 company shares - Stock Titan
OneDigital Investment Advisors LLC Purchases 4,642 Shares of Insulet Corporation $PODD - MarketBeat
What are Wall Street analysts' target price for Insulet stock? - MSN
Insulet Corp (PODD) Shares Down 3.83% on Feb 20 - GuruFocus
Former Insulet CEO Chosen to Lead BVI - Medical Product Outsourcing
Raymond James Financial Has Lowered Expectations for Insulet (NASDAQ:PODD) Stock Price - MarketBeat
Alberta Investment Management Corp Takes Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):